- ►iovs.org A Klettner, J Roider - Investigative Ophthalmology & Visual Science, 2008 - ARVO PURPOSE. Vascular endothelial growth factor (VEGF) antagonists are the therapy of choice for
age-related macular degeneration. Ranibizumab and pegaptanib have been approved by the United States
Food and Drug Administration, ... Cited by 10 - Related articles - All 8 versions
J Wang, W Zhao, Y Guo, B Zhang, Q Xie, D Xiang, J … - Oncology, 2009 - content.karger.com The expression levels of the RNA-binding protein Hu antigen (HuR) and vascular endothelial growth
factor-C (VEGF-C) were examined immunohistochemically in 81 non-small cell lung cancers (NSCLC) and
15 benign human lung tissues. HuR ... Related articles - All 4 versions
R Kannan, N Zhang, PG Sreekumar, CK Spee, A … - Mol Vis, 2006 - molvis.org Methods: Long-term culture of ARPE-19 cells in Dulbecco's modified Eagle medium (DMEM)/F12
containing 1% fetal bovine serum (FBS) on transwell filters (12 mm or 6 mm, pore size 0.4 μm) was
performed to produce polarized ... Related articles - Cached - All 2 versions